- Company Details
Oncology remains a major market of unmet need. BNOAT Oncology¿s long-term objective is New Drug Approval of its lead candidate nitrosylcobalamin, a tumor-specific, apoptosis-inducing, anti-cancer dru ...SBIR Phase I 2010 Department of Health and Human Services
BNOAT ONCOLOGY, INC.
AKRON, OH, 44311-1051
|# of Employees:||0|
|Socially and Economically Disadvantaged:||N|